Product Description
Pill imprint Pfizer STN 12.5 mg has been identified as Sutent 12.5 mg.
Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
943total visits,1visits today
Reviews
There are no reviews yet.